Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.

Background: Cryptococcal meningitis (CM) is a common HIV-associated opportunistic-infection worldwide. Existing literature focusses on hospital-based outcomes of induction treatment. This paper reviews outpatient management in integrated primary care clinics in Yangon.Method: This retrospective case...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Infectious Diseases Vol. 21; no. 1; pp. 1 - 7
Autores principales: Warrell, Clare E., Macrae, Catriona, McLean, Alistair R. D., Wilkins, Edmund, Ashley, Elizabeth A., Smithuis, Frank, Tun, Ni Ni
Formato: Journal Article
Publicado: BioMed Central 4/21/2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=149923856&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 149923856
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14712334
        1CHU
      jtl: BMC Infectious Diseases
      issn: 14712334
      maglogo: N
    pubinfo:
      dt: 4/21/2021
      vid: 21
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        149923856
        149923856
        NLM33882845
        10.1186/s12879-021-06049-z
        NLM33882845
        149923856
      ppf: 1
      ppct: 6
      formats:
      tig:
        atl: Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
      aug:
        au:
          Warrell, Clare E.
          Macrae, Catriona
          McLean, Alistair R. D.
          Wilkins, Edmund
          Ashley, Elizabeth A.
          Smithuis, Frank
          Tun, Ni Ni
        affil: Myanmar Oxford Clinical Research Unit (MOCRU), Yangon, Myanmar
      sug:
        subj:
          AIDS-Related Opportunistic Infections Complications
          Meningitis, Cryptococcal Drug Therapy
          Human Immunodeficiency Virus
          Meningitis, Cryptococcal Complications
          Cryptococcus Immunology
          Amphotericin B Administration and Dosage
          Fluconazole Administration and Dosage
          Bile Acids and Salts Administration and Dosage
          Antifungal Agents Administration and Dosage
          Primary Health Care
          Administration, Intravenous
          Retrospective Design
          Adult
          Fluconazole Adverse Effects
          Meningitis, Cryptococcal Epidemiology
          Bile Acids and Salts Adverse Effects
          Treatment Outcomes
          Young Adult
          AIDS-Related Opportunistic Infections Epidemiology
          Antifungal Agents Adverse Effects
          Myanmar
          Cryptococcus
          Middle Age
          Drug Combinations
          Drug Therapy, Combination
          Phlebitis Chemically Induced
          Female
          Male
          Administration, Oral
          Amphotericin B Adverse Effects
          Meningitis, Cryptococcal Microbiology
          Adolescence
          AIDS-Related Opportunistic Infections
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Adolescent: 13-18 years
          Female
          Male
      ab: Background: Cryptococcal meningitis (CM) is a common HIV-associated opportunistic-infection worldwide. Existing literature focusses on hospital-based outcomes of induction treatment. This paper reviews outpatient management in integrated primary care clinics in Yangon.Method: This retrospective case note review analyses a Myanmar HIV-positive patient cohort managed using ambulatory induction-phase treatment with intravenous amphotericin-B-deoxycholate (0.7-1.0 mg/kg) and oral fluconazole (800 mg orally/day).Results: Seventy-six patients were diagnosed between 2010 and 2017. The median age of patients diagnosed was 35 years, 63% were male and 33 (45%) were on concurrent treatment for tuberculosis. The median CD4 count was 60 at the time of diagnosis. Amphotericin-B-deoxycholate infusions precipitated 56 episodes of toxicity, namely hypokalaemia, nephrotoxicity, anaemia, febrile reactions, phlebitis, observed in 44 patients (58%). One-year survival (86%) was higher than existing hospital-based treatment studies.Conclusion: Ambulation of patients in this cohort saved 1029 hospital bed days and had better survival outcomes when compared to hospital-based studies in other resource constrained settings.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N